Hepatitis
SARS-CoV-2 may trigger autoimmune processes — T-cells attacking both the virus and the host's own cells — that may be involved in recent cases of hepatitis.
Scientists identified mutations in SARS-CoV-2 that cause the virus's proteins to strongly resemble proteins belonging to the host (e.g., infected individuals).